Achieving Optimal Patient Outcomes After Frontal Sinus Endoscopy

Aims: Evaluating the Role of Biodegradable Drug-Eluting Stents in Enhancing Outcomes after Frontal Endoscopic Sinus Surgery. Study Design: Prospective case control study. Place and Duration of Study: The Department of Otorhinolaryngology in Almoosa Specialist Hospital, Al Ahsa, Saudi Arabia, and Helwan University Hospital (Badr Hospital), Egypt. From March 2025 to December 2025. Methodology: A total of 42 adult participants were enrolled and randomly assigned to either the Propel stent group (n=21) or the control group (n=21). Participants were monitored for nine months through clinical and radiographic evaluations, focusing on outcomes such as patency of the ostium, presence of adhesions, and recurrence of polyps. Results: After nine months, the Propel stent group exhibited significantly higher ostium patency rates compared to the controls. Additionally, lower rates of stenosis, retained secretions, adhesions, and polyp formation were observed in the Propel stent group. Conclusion: Propel stents significantly enhance frontal sinus patency and reduce the occurrence of postoperative adhesions and polyp recurrence in comparison to non-drug-eluting stents.